NCT05254301

Brief Summary

Long COVID is a new phenomenon, in which individuals who experienced a SARS-CoV-2 infection still experience one or more symptoms, such as exercise intolerance, fatigue and/or muscle pains in addition to other COVID-related symptoms, weeks to months after initial infection. The aim of this pilot-study is to learn about which complaints patients continue to experience after their infection and how this affects their lives to a greater or lesser extent and whether a patient-tailored physical rehabilitation programme combined with individualised nutritional therapy leads to a faster recovery compared to a classic exercise program with the physiotherapist.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P25-P50 for not_applicable covid19

Timeline
Completed

Started Apr 2022

Longer than P75 for not_applicable covid19

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 19, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 24, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

April 24, 2022

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2024

Completed
Last Updated

May 8, 2024

Status Verified

May 1, 2024

Enrollment Period

1.8 years

First QC Date

February 19, 2022

Last Update Submit

May 7, 2024

Conditions

Keywords

NutritionPilot StudyPhysical Therapy

Outcome Measures

Primary Outcomes (1)

  • 1-minute sit-to-stand (1-MSTS)

    Testing of endurance and muscle strength of the lower extremities (standing up from a sitting position for as many repetitions as possible during 1 minute)

    Change from Baseline Repetitions Sit-To-Stand's in one minute at 12 weeks

Secondary Outcomes (5)

  • Multi-dimensional Fatigue Inventor (MFI-20)

    Change from Baseline MFI-20 at 12 weeks, at 6 weeks intervention, at 12 weeks, and at 6 weeks post-intervention.

  • EuroQol five-dimensional (five-level version) (EQ-5D-5L)

    Change from Baseline EQ-5D-5L at 12 weeks, at 6 weeks intervention, at 12 weeks, and at 6 weeks post-intervention.

  • Post-COVID-19 Functional Status (PCFS)

    Change from Baseline PCFS at 12 weeks, at 6 weeks intervention, at 12 weeks, and at 6 weeks post-intervention.

  • Hospital Anxiety and Depression Scale (HADS)

    Change from Baseline HADS at 12 weeks, at 6 weeks intervention, at 12 weeks, and at 6 weeks post-intervention.

  • Work Productivity and Activity Impairment (WPAI)

    Change from Baseline WPAI at 12 weeks, at 6 weeks intervention, at 12 weeks, and at 6 weeks post-intervention.

Other Outcomes (8)

  • Muscle strength

    Change from Baseline muscle strength at 12 weeks, at 6 weeks intervention, at 12 weeks, and at 6 weeks post-intervention.

  • Handgrip strength

    Change from Baseline handgrip strength at 12 weeks, at 6 weeks intervention, at 12 weeks, and at 6 weeks post-intervention.

  • 6-minute walk test (6-MWT)

    Change from Baseline 6-MWT at 12 weeks, at 6 weeks intervention, at 12 weeks, and at 6 weeks post-intervention.

  • +5 more other outcomes

Study Arms (2)

Personalized multimodal treatment

EXPERIMENTAL

A combination of biometric parameter oriented nutritional counseling and a tailored physical training program.

Other: Intervention group

Standard care

ACTIVE COMPARATOR

Physiotherapy with standard care advice for gradual cardiorespiratory and resistance training. (In this standard care setting, nutritional screening nor counseling is included.)

Other: Intervention group

Interventions

This personalised multimodal treatment considers evidence- and practice-based elements (e.g., self-management, individual guidance \& follow-up, low-threshold activities, homebased functional training \& better follow-up guidance afterwards).

Personalized multimodal treatmentStandard care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to understand and sign written consent in Dutch, French or English
  • Laboratory (PCR and/or serology) confirmed infection with SARS-CoV-2 less than 12 months ago
  • Persisting functional difficulties and symptoms: exercise intolerance and/or fatigue and/or muscle pain beyond 12 weeks beside other COVID-related symptoms (e.g., loss of taste and/or smell)
  • Patient affiliated to a social security system

You may not qualify if:

  • Patients unable to comprehend oral and/or written instructions, questionnaires in English, French or Dutch.
  • Patient currently suffers from any other disease beside long COVID that could explain the symptoms (e.g., fibromyalgia, Sjögren disease, severe anaemia...)
  • Patient is unable to undergo a rehabilitation programme due to comorbidities (e.g., major cardiovascular disease such as myocarditis or severe dementia), as decided on by the medical study team members.
  • Patient currently benefiting from physiotherapy sessions with focus on motor and/or respiratory therapy for COVID-19 or any other unrelated disease
  • Patients with metabolic disorders or severe gastro-intestinal conditions (e.g. short bowel syndrome)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitair ziekenhuis Brussel

Brussels, 1090, Belgium

Location

Related Publications (1)

  • Roggeman S, Jimenez Garcia BG, Leemans L, Demol J, Geers J, De Smedt A, Putman K, Schiltz M, Beckwee D, De Waele E. Functional performance recovery after individualized nutrition therapy combined with a patient-tailored physical rehabilitation program versus standard physiotherapy in patients with long COVID: a pilot study. Pilot Feasibility Stud. 2023 Sep 28;9(1):166. doi: 10.1186/s40814-023-01392-1.

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Elisabeth De Waele, MD, PhD

    Universitair Ziekenhuis Brussel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 19, 2022

First Posted

February 24, 2022

Study Start

April 24, 2022

Primary Completion

January 30, 2024

Study Completion

January 30, 2024

Last Updated

May 8, 2024

Record last verified: 2024-05

Locations